Filing Details
- Accession Number:
- 0001140361-12-038873
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-29 21:46:04
- Reporting Period:
- 2012-08-27
- Filing Date:
- 2012-08-29
- Accepted Time:
- 2012-08-29 21:46:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070698 | Raptor Pharmaceutical Corp | RPTP | Pharmaceutical Preparations (2834) | 860883978 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1362490 | Todd Zankel | C/O Raptor Pharmaceutical Corp. 9 Commercial Blvd., Suite 200 Novato CA 94949 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-08-27 | 287 | $2.02 | 669,637 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-27 | 287 | $5.00 | 669,350 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock options (right to buy) | Acquisiton | 2012-08-27 | 287 | $0.00 | 287 | $2.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 312,563 | 2010-03-09 | 2020-03-08 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.
- Original option grant vests 6/48ths on March 9, 2010 and 1/48th per month thereafter.
Billionaire Hedge Funds
